2010China Medical HeraldRequires access

Clinical observation of Edaravone in the treatment of 44 patients with cerebral infarction

Shixiu Wang

Open publisher page 0 citations

Abstract

Objective:To observe the efficacy and adverse reactions of Edaravone in the treatment of cerebral infarction.Methods:60 patients with acute cerebral infarction were randomly divided into two groups,20 cases of the control group were treated by routine therapy,the experimental group added Edaravone,after 2 weeks,we evaluated the efficacy.Results:The experimental group has obvious effects and less adverse reactions.Conclusion:Edaravone in the treatment of acute cerebral infarction is safe and effective.

About this research paper

What this paper is about

Objective:To observe the efficacy and adverse reactions of Edaravone in the treatment of cerebral infarction.Methods:60 patients with acute cerebral infarction were randomly divided into two groups,20 cases of the control group were treated by routine therapy,the experimental group added Edaravone,after 2 weeks,we evaluated the efficacy.Results:The experimental group has obvious effects and less adverse reactions.Conclusion:Edaravone in the treatment of acute cerebral infarction is safe and effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the efficacy and adverse reactions of Edaravone in the treatment of cerebral infarction.Methods:60 patients with acute cerebral infarction were randomly divided into two groups,20 cases of the control group were treated by routine therapy,the experimental group added Edaravone,after 2 weeks,we evaluated the efficacy.Results:The experimental group has obvious effects and less adverse reactions.Conclusion:Edaravone in the treatment of acute cerebral infarction is safe and effective.

Key concepts: Edaravone, Medicine, Cerebral infarction, Clinical efficacy, Adverse effect, Anesthesia, Conventional treatment, Brain infarction

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of Edaravone in the treatment of 44 patients with cerebral infarction — Research Paper | ScholarLens